Pdt Partners, LLC Homology Medicines, Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $41,358 - $66,332	-15,907 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $57,901 - $123,756	15,907 New	15,907 $58,000
Q2 2021 Aug 16, 2021	SELL	$6.02 - $9.64 $95,675 - $153,208	-15,893 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $24,648 - $39,782	2,688 Added 20.36%	15,893 $150,000
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $35,082 - $52,269	-3,933 Reduced 22.95%	13,205 $149,000
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $48,755 - $81,373	4,905 Added 40.1%	17,138 $183,000
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $147,652 - $236,586	12,233 New	12,233 $186,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.